ARL Signals Attock Hospital Exit, Refocuses on Core Refining

Attock Refinery Limited (ARL) announced that the Board of Directors of Attock Refinery Limited (ARL) is considering disinvesting its shareholding in its wholly owned subsidiary Attock Hospital (Pvt.) Limited (AHL). This consideration would help management to focus on ARL‘s core refining business.

As part of this consideration, an Expression of Interest would be requested to explore Joint Venture opportunities. Under such arrangements, management control may also be offered to a prospective partner on such terms and conditions as may be mutually agreed. Final decision in this respect would be taken after a comprehensive evaluation of all available options and relevant factors. ARL will keep stakeholders duly informed of any significant developments as the process progresses.

📢 Announcement: We're on WhatsApp – Join Us There! 

According to the KSEStocks Database, ARL is covered by 2 analysts in Pakistan and they have an average price rating of PKR 1016. This average price target suggests an upside of 58.6% from the last close of PKR 640.81.

According to EPS estimates from 2 different brokers, ATRL has an average 2026 EPS expectation of 80. This suggests the stock is now trading at a forward PE of 8.6.

Why do we compile research firms’ forecasts? Broker research is fragmented across different houses. Compiling it in one place helps investors see consensus, identify divergence, and think independently rather than relying on a single view.

You can get access to our database for a small fee of PKR 333 per month (PKR 999 per quarter). You can get in touch with us via WhatsApp:

⚠️ This post reflects the author’s personal opinion and is for informational purposes only. It does not constitute financial advice. Investing involves risk and should be done independently. Read full disclaimer →